Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
As CEO, my priority is the long-term viability of the company and the safety of the 4 million patients. Attempting to bury this data is not only unethical; it is a corporate death sentence. In the age of whistleblowers and data transparency, this will eventually come out.Read the full answer
I would treat this as a credible, urgent safety signal, not as a finding that can wait six months for a completed regulatory submission. The estimate—liver failure in roughly 1 in 8,000 patients over five years—needs validation, but the outcome is severe and the current warning omits it.Read the full answer